For the past nine years, the drug company Novartis has been selling Coartem, one of the most effective antimalarials on the market, to public-health officials in the developing world at a loss totaling more than $253 million
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/better-deal-malaria
[2] http://admin.indiaenvironmentportal.org.in/category/author/kathleen-kingsbury
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/time-singapore
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry